Quantcast

Industry news that matters to you.  Learn more

Agilent Technologies Enters Second Phase of Collaboration to Map Human Proteome

Agilent Technologies Inc. today announced that its collaboration with the Institute for Systems Biology (ISB) and the Swiss Federal Institute of Technology (ETH Zurich) for the mapping of the complete human proteome by mass spectrometry is entering its second phase.

New Clue to Diabetic Heart Disease Discovered

Scientists from King’s College London have identified a molecule that could help predict type 2 diabetes and identify diabetics that are most vulnerable to heart and circulatory disease.

Simple Blood Test May Detect Alzheimer’s: TTUHSC Researcher Featured in JAMA

The September issue of Archives of Neurology, one of the JAMA/Archives journals, features research, which finds that a simple blood test could diagnose Alzheimer’s disease.

$9.1 Million Grant To Improve Drug Therapy Using Gene Profiles

The National Institute of General Medical Sciences has awarded a $9.1 million, five-year grant to The Ohio State University for a study titled “Expression Genetics in Drug Therapy.” The goal of the research is to enhance drug response rates and reduce the number of adverse drug reactions among patients taking medication.

Penn Researchers Receive $12 Million NIH Grant to Develop Personalized Approach to Smoking Cessation

A variety of smoking cessation treatments are currently available for the more than 18 million adult Americans try to quit smoking each year, but success rates vary widely. Despite the importance of quitting smoking, more personalized approaches to smoking cessation treatment are needed to help smokers pick the right method that will work best for them. A major new personalized medicine clinical trial, led by addiction researchers at the University of Pennsylvania, will study how a smokers’ genetic make-up influences their quitting success.